Home › Cancro (tutti i tipi) › Hawaii › Honolulu
Studi clinici su Cancro (tutti i tipi) a Honolulu, HI
13 studi su Cancro (tutti i tipi) cercano partecipanti presso sedi a Honolulu e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
In reclutamentoFase 2/3
- Invision, LLC, Honolulu
- University of Hawaii Cancer Center, Honolulu
- Cardiology Associates, Inc, ‘Aiea · a 7 mi di distanza
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
In reclutamentoFase 3
- Kaiser Permanente Moanalua Medical Center /ID# 238363, Honolulu
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
In reclutamentoFase 2
- The Queen's Medical Center - POB I, Honolulu
- The Queen's Medical Center - Punchbowl, Honolulu
- The Queen's Medical Center - Kuakini, Honolulu
- e altri 1
Connect for Cancer Prevention Study (Connect)
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Kaiser Permanente Hawaii, Honolulu
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
In reclutamentoFase 2
- Hawaii Pacific Neuroscience, Honolulu
A Prospective Study to Develop and Clinically Validate an in Vitro Diagnostic Medical Device That Uses Blood to Classify Patients at High Risk for Breast Cancer
In reclutamentoStudio osservazionale
- Univercity of Hawaii Cancer Center, Honolulu
Project: Every Child for Younger Patients With Cancer
In reclutamentoStudio osservazionale
- Kapiolani Medical Center for Women and Children, Honolulu
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
In reclutamentoFase 3
- Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu
- Queen's Cancer Cenrer - POB I, Honolulu
- Queen's Medical Center, Honolulu
- e altri 10
EXoPERT EMERALD Clinical Study
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- University of Hawaii Cancer Center, Honolulu
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
In reclutamentoFase 2/3
- Kaiser Permanente Moanalua Medical Center /ID# 275942, Honolulu
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
In reclutamento
- Spark M. Matsunaga VA Medical Center, Honolulu
CTNow: A Clinical Trials Education Program for Rural Cancer Patients and Oncology Providers
In reclutamentoVolontari sani benvenuti
- Univesity of Hawaii Cancer Center, Honolulu
GEMINI-NSCLC: NSCLC Biomarker Study
In reclutamentoStudio osservazionale
- Hawaii Cancer Care, Honolulu
Studi su Cancro (tutti i tipi) in altre città
- Houston, TX121 studi
- New York City, NY110 studi
- Boston, MA86 studi
- Los Angeles, CA73 studi
- Nashville, TN65 studi
- Philadelphia, PA59 studi
- Durham, NC58 studi
- Washington, DC58 studi
- Chicago, IL51 studi
- Seattle, WA49 studi
- Atlanta, GA49 studi
- Arlington, VA48 studi
Altri studi a Honolulu
- Obesità13 studi
- Cancro al seno12 studi
- Sovrappeso11 studi
- Cancro del polmone non a piccole cellule10 studi
- Cancro ai polmoni8 studi
- Leucemia mieloide acuta7 studi
- Diabete di tipo 27 studi
- Cancro ovarico7 studi
- Cancro pancreatico7 studi
- Neuroblastoma6 studi
- Cancro alla prostata5 studi
- Linfoma di Burkitt5 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.